Evidence map›Paper›PMID 32681117›Full record

ArticleJournal of human genetics2020

An NGS-based genotyping in LQTS; minor genes are no longer minor.

Seiko Ohno, Junichi Ozawa, Megumi Fukuyama, Takeru Makiyama, Minoru Horie

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. SCN5A variant type-dependent risk prediction in Brugada syndrome.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  2. Article
  3. Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  4. Review
  5. Article
  6. Journal of arrhythmia · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Seiko OhnoDepartment of Bioscience and Genetics, National Cerebral and Cardiovascular Center, Suita, Japan. sohno@ncvc.go.jp.ORCID http://orcid.org/0000-0003-1209-8896
Junichi OzawaDepartment of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Megumi FukuyamaDepartment of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.
Takeru MakiyamaDepartment of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Minoru HorieCenter for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan.
Shiga University of Medical Science · JPKyoto University · JPNiigata University · JP

Funding

Japan Agency for Medical Research and Development (AMED) JP17ek0109202Japan Agency for Medical Research and Development (AMED) JP17ek0109219Japan Agency for Medical Research and Development (AMED) JP17ek0109294MEXT | Japan Society for the Promotion of Science (JSPS) 17K15999MEXT | Japan Society for the Promotion of Science (JSPS) 18K07875Ministry of Health, Labour and Welfare (Ministry of Health, Labour and Welfare, Japan) H27-032Ministry of Health, Labour and Welfare (Ministry of Health, Labour and Welfare, Japan) H29-055
6 · The paper itself

Abstract

Mutations in KCNQ1, KCNH2, and SCN5A are the major cause of long QT syndrome (LQTS). More than 90% of the genotyped patients have been reported to carry mutations in any of these three genes. Thanks to increasing popularity of next generation sequencer (NGS), novel CACNA1C mutations have been identified among LQTS patients without extra-cardiac phenotypes. We aimed to clarify the frequency of genotypes in LQTS patients in the era of NGS. The study comprised 160 congenital LQTS patients (71 males) registered from November 2015 to September 2018. Inclusion criteria was QTc > 460 ms and Schwartz score ≥ 3. We performed genetic analysis using target gene method by NGS and confirmed the mutations by Sanger method. The median age for genetic screening was 13 (0-68) years. Sixteen patients suffered cardiac arrest, 47 syncope, and 97 were asymptomatic. We identified genetic mutations in 111 (69.4%) patients including 6 CACNA1C (5.4% of the genotyped patients) with 4 asymptomatic patients. Five (3.1%) patients carried double mutations; three out of them with RYR2 and KCNQ1 or KCNH2. In conclusion, CACNA1C screening would be recommended even if the patient is asymptomatic to elucidate the genetic background of the LQTS patients.

Indexed as

Genetic Predisposition to DiseaseAdolescentAdultAgedCalcium Channels, L-TypeChildChild, PreschoolERG1 Potassium ChannelFemaleGenotypeHigh-Throughput Nucleotide SequencingHumansInfantInfant, NewbornKCNQ1 Potassium ChannelLong QT SyndromeCACNA1C protein, humanCalcium Channels, L-TypeERG1 Potassium ChannelKCNH2 protein, humanKCNQ1 Potassium ChannelKCNQ1 protein, humanNAV1.5 Voltage-Gated Sodium ChannelRyanodine Receptor Calcium Release ChannelRyR2 protein, humanSCN5A protein, human

Identifiers

PMID32681117
OpenAlexW3043287476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.